Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Jubert

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Anesthesiology|November 7, 1999
Compound A uptake and metabolism to mercapturic acids and 3,3,3-trifluoro-2-fluoromethoxypropanoic acid during low-flow sevoflurane anesthesia: biomarkers for exposure, risk assessment, and interspecies comparisonE D Kharasch, C Jubert
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|November 22, 2005
[Targeted therapies in pediatric oncology: a new therapeutic approach?]C Jubert, B Geoerger, J Grill, et al.
Toxicology and Applied Pharmacology|September 30, 1999
Dose-dependent metabolism of fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A), an anesthetic degradation product, to mercapturic acids and 3,3,3-trifluoro-2-(fluoromethoxy)propanoic acid in ratsE D Kharasch, C Jubert, D K Spracklin, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 22, 1999
Duration of cytochrome P-450 2E1 (CYP2E1) inhibition and estimation of functional CYP2E1 enzyme half-life after single-dose disulfiram administration in humansM G Emery, C Jubert, K E Thummel, et al.
Bone Marrow Transplantation|May 4, 2010
Engraftment of unrelated cord blood after reduced-intensity conditioning regimen in children with refractory neuroblastoma: a feasibility trialC Jubert, D A Wall, M Grimley, et al.
Journal of Clinical Pharmacology|July 7, 1999
Intraindividual variability in male hepatic CYP3A4 activity assessed by alfentanil and midazolam clearanceE D Kharasch, C Jubert, T Senn, et al.
Annales De Dermatologie Et De Venereologie|September 25, 1998
[Cutaneous malacoplakia: a pediatric case]O Enjolras, J Guillemette, A Carlotti, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 29, 1999
Lack of single-dose disulfiram effects on cytochrome P-450 2C9, 2C19, 2D6, and 3A4 activities: evidence for specificity toward P-450 2E1E D Kharasch, D C Hankins, C Jubert, et al.
Annales De Dermatologie Et De Venereologie|October 19, 2005
[Methotrexate for the treatment of patients with chronic cutaneous sarcoidosis: 4 cases]A Gary, A-B Modeste, C Richard, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 22, 2012
Adenovirus infections in Bordeaux University Hospital 2008-2010: clinical and virological featuresS Berciaud, F Rayne, S Kassab, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Anesthesiology|November 7, 1999
Compound A uptake and metabolism to mercapturic acids and 3,3,3-trifluoro-2-fluoromethoxypropanoic acid during low-flow sevoflurane anesthesia: biomarkers for exposure, risk assessment, and interspecies comparisonE D Kharasch, C Jubert
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|November 22, 2005
[Targeted therapies in pediatric oncology: a new therapeutic approach?]C Jubert, B Geoerger, J Grill, et al.
Toxicology and Applied Pharmacology|September 30, 1999
Dose-dependent metabolism of fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A), an anesthetic degradation product, to mercapturic acids and 3,3,3-trifluoro-2-(fluoromethoxy)propanoic acid in ratsE D Kharasch, C Jubert, D K Spracklin, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 22, 1999
Duration of cytochrome P-450 2E1 (CYP2E1) inhibition and estimation of functional CYP2E1 enzyme half-life after single-dose disulfiram administration in humansM G Emery, C Jubert, K E Thummel, et al.
Bone Marrow Transplantation|May 4, 2010
Engraftment of unrelated cord blood after reduced-intensity conditioning regimen in children with refractory neuroblastoma: a feasibility trialC Jubert, D A Wall, M Grimley, et al.
Journal of Clinical Pharmacology|July 7, 1999
Intraindividual variability in male hepatic CYP3A4 activity assessed by alfentanil and midazolam clearanceE D Kharasch, C Jubert, T Senn, et al.
Annales De Dermatologie Et De Venereologie|September 25, 1998
[Cutaneous malacoplakia: a pediatric case]O Enjolras, J Guillemette, A Carlotti, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 29, 1999
Lack of single-dose disulfiram effects on cytochrome P-450 2C9, 2C19, 2D6, and 3A4 activities: evidence for specificity toward P-450 2E1E D Kharasch, D C Hankins, C Jubert, et al.
Annales De Dermatologie Et De Venereologie|October 19, 2005
[Methotrexate for the treatment of patients with chronic cutaneous sarcoidosis: 4 cases]A Gary, A-B Modeste, C Richard, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 22, 2012
Adenovirus infections in Bordeaux University Hospital 2008-2010: clinical and virological featuresS Berciaud, F Rayne, S Kassab, et al.
Pageof 2